In this World of Cannabis interview, watch Caroline Cahill, Managing Editor of Marijuana Industry News, interview Ryan Brown, Co-founder of Tetra Bio Pharma.
Tag Archives: Canada
LEAMINGTON, Ontario, March 21, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF), a Health Canada Licensed Producer of medical cannabis products, today announced that the common shares (the “Common Shares”) of the Company will begin trading on the Toronto Stock Exchange (“TSX”) as of the open of the market on March 22, 2017.
Marijuana has quickly become the next “can’t miss” investing idea for investors across North America. Despite this huge potential market, people are reluctant to put any of their cash into this market
Canopy Growth Corporation (TSX:WEED) is being added to the influential S&P/TSX Composite Index in another milestone for Canada’s fledgling marijuana industry.
LOS ANGELES, March 13, 2017 /Weed Wire/ — As cannabis replaces tech as the fastest growing industry in the U.S., legal marijuana is getting a big boost from tech’s past success.
The California Cannabis Business Expo wound down on March 8, closing with two panels at the Marijuana Investor Summit: one featuring the CEOs of three U.S. based firms active in the cannabis space; the other featuring four business and financial executives from Canada, who could speak to the state of the same industry in a very different legal and cultural context.
Publicly-traded marijuana companies had a rough week but got a bounce Thursday following news of raids at the Cannabis Culture dispensary chain owned by Marc and Jodie Emery.
As investors flock to Canada’s burgeoning marijuana sector, Prime Minister Justin Trudeau’s government is signaling recreational pot sales aren’t imminent.
Reports continue to emerge of young teens overdosing and sometimes dying due to the use of drugs containing fentanyl, a potent synthetic opioid. Smoking pot is different than popping pills, but the risk for the government is that the lines might get blurred quite quickly in the eyes of parents who are trying to protect their kids from the current opioid threat.
According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.
VANCOUVER, British Columbia, Feb. 27, 2017 /Weed Wire/ — ICC International Cannabis Corporation (“ICC” or the “Company”) (TSXV: ICC) is pleased to announce that it has entered into a memorandum of understanding and presale agreement (the “MOU and Presale Agreement”) with Emblem Corp. (TSXV: EMC; OTCQB: EMMBF), who through a wholly-owned subsidiary, is a licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations overseen by Health Canada.
Shares of Canadian and U.S. marijuana producers fell Friday after the Trump administration suggested a crackdown on recreational marijuana may be in the works.
VANCOUVER, British Columbia, Feb. 22, 2017 /Weed Wire/ — MYM Nutraceuticals Inc. (CSE:MYM) (the “Company” or “MYM”) is pleased to announce that it has completed its acquisition of a majority interest in Sublime Culture Inc. (“Sublime”) and its inspection-stage application to become a Licensed Producer of medical cannabis.
SMITH FALLS, Ontario, Feb. 17, 2017 /Weed Wire/ — Canopy Growth Corporation (TSX: WEED) (“Canopy Growth” or the “Corporation”) announced that it has renewed the engagement agreement (“agreement”) with XIB Consulting Inc. (“XIB”) that the Corporation announced on April 7, 2016 and subsequently renewed October 7, 2016.
TORONTO, Ontario, Feb. 16, 2017 /Weed Wire/ — Bill Blair, Parliamentary Secretary to the Minister of Justice and Attorney General of Canada Jody Wilson-Raybould, has started a cross-country tour to discuss the legalization and regulation of cannabis.
NANAIMO, British Columbia, Feb. 14, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary approvals in Canada and New Zealand to export medical cannabis to New Zealand.
Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.
“We are continuing to see Canadian companies invest in or acquire assets in U.S. cannabis markets […] looking to take advantage of increased demand abroad,” a Viridian Capital analyst says.
On Feb. 7, 2017, Health Canada announced that it is going to start random testing of medical marijuana produced by all of the country’s licensed producers in an attempt to ensure patients aren’t being exposed to contaminated products.
Roto-Gro International, a Canadian cannabis-tech company has been admitted to the ASX, and has become the latest player to join the list of cannabis based companies on the ASX.
OTTAWA, Ontario, Feb. 7, 2017 /Weed Wire/ — Recently, two licensed producers of cannabis for medical purposes undertook voluntary recalls of cannabis products that contained low levels of prohibited pest control products (myclobutanil/bifenazate/pyrethrins).
Canopy Growth Corporation’s generating eye-popping returns for investors. However, there are risks ahead that could rein in some investor optimism.
Marijuana prices are falling. Could marijuana stock prices drop soon, too?
On the face of it, 2017 may be the year to jump into the marijuana market to get a piece of what looks to be promising growth over the next few years.
As of Wednesday, traders on the Toronto Stock Exchange can buy and sell “WEED.”
Chris Blake, Senior Portfolio Manager, TD Wealth, explains what investors need to know before buying marijuana stocks.
On Jan. 10, 2017, Health Canada authorized James E. Wagner Cultivation in Ontario to start cultivating medical cannabis, making it the 38th licensed producer in Canada and the first producer of 2017 licensed under the Access to Cannabis for Medical Purposes Regulations.
On Jan. 24, 2017, Ontario-based Loyalist College announced that it had been approved by Health Canada for a Controlled Drugs and Substances Licence to test and analyze medical cannabis.
Marijuana Index Review for 2017, United States and Canada Medical Cannabis Market website and it’s different features for stocks, and my input on investing.
Loyalist College has received approval from Health Canada for a Controlled Drugs and Substances Licence for the purpose of research and analysis using medical cannabis.
“Obtaining our license to sell cannabis oils is another major milestone for Aurora, said Terry Booth, chief executive.
The market for marijuana is exploding as Americans overwhelmingly embrace legalization. Analysts are projecting tens of billions of dollars in future marijuana sales, making this an intriguing market for investors.
CALGARY, Alberta, Jan. 20, 2017 /Weed Wire/ — Maple Leaf Green World (MGW-V) (“Maple Leaf” or the “Company”) is pleased to announce that, after careful consideration of other options, the Company intends to build a new facility for its Nevada operations, using the same site BioNeva Innovations of Henderson LLC (“BioNeva”) employed to obtain its cultivation permit (the “Permit”).
North Americans spent $53.3 billion on legal, illegal, and medical marijuana in 2016, according to a Jan. 17, 2017, release from Arcview Research Group. That’s more than people in the United States spent on McDonald’s and Starbucks combined.
LOS ANGELES, Jan. 13, 2017 /Weed Wire/ — MJIC Inc. has completed its quarterly rebalancing of the Marijuana Index, adding 11 new cannabis companies to its North American Marijuana Index.
Canopy Growth Corp. (TSX:CGC) has been on a wild ride in recent months, and investors who think the name has long-term potential are trying to decided when they should buy.
U.S. estimates by investment bank Cowen and Company suggest cannabis sales will increase at a compound annual growth rate of 23% over the next decade to US$50 billion. In Canada, it’s estimated that 5.2 million Canadians will consume legalized pot annually by 2021.
Anandia Labs co-founder Jonathan Page agreed to sell 20% of his company to CannaRoyalty because he appreciates CannaRoyalty’s expertise in extraction and post-processing.
Veritas Pharma Inc. (the “Company”) (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), is pleased to announce that a non-brokered private placement offering of up to 9,090,910 units (“Units”) at a price of $0.22 per Unit for aggregate gross proceeds of up to $2,000,000 (the “Offering”).
Olympic snowboarder Ross Rebagliati wants to visit the United States to promote Ross’ Gold, his Canadian cannabis brand; however, with Rebagliati having admitted past marijuana use, U.S. Border Agents have used a border policy to prevent him from entering the country.
OAKLAND, Calif., Jan. 3, 2016 /Weed Wire/ — Arcview Market Research, the leading publisher of cannabis market research, released a new 2016 North American cannabis market size estimate as well as projections for the market through 2021, while announcing the availability of presales of its 5th edition of the State of Legal Marijuana Markets Report.
Further details of recall revealed that there has been a detection of an unwanted pesticide, which is not registered for use on marijuana, under the Pest Control Products Act.
On Dec. 30, 2016, Canadian Armed Forces veterans began reporting a privacy breach by Veterans Affairs Canada, as the VAC sent letters to veterans in the federal medical marijuana program with “RE: Cannabis for Medical Purposes” visible in the envelope window.
Most myths have at least a little bit of truth interspersed with a lot that is false. That’s the case with these three myths about marijuana stocks that some might mistakenly believe.
CanniMed Therapeutics Inc. became the latest and last medical marijuana company Thursday to go public in 2016, capping off a banner year in the burgeoning sector.
Marijuana is the most widely cultivated, produced and consumed drug worldwide, and more than 20 countries worldwide are trialing legislation regarding access to marijuana and exploring possible benefits.
Here are three stocks that have doubled investors’ money in 2016, and a look into whether or not they can continue to rally in 2017.
In the last few months, the medical marijuana growers have dominated the trading activity on the TSX Venture in terms of dollar volume almost exclusively, belying a persistent interest from investors in Canada and the United States.
Toronto police are investigating an alleged armed robbery at the medical marijuana dispensary Canna Clinic on Ossington Avenue which the shop’s owners never reported.
Viridian Capital Advisors recently reported the global cannabis industry has raised more than $1 billion in 2016, according to Forbes. Most of the $1 billion-plus in capital investments was raised in the United States and Canada, with other countries contributing small amounts, Scott Greiper of Viridian said.